Atlas Trials

A Study of MCARH109 and MCARH125 in People With Multiple Myeloma

Clinical trial NCT05431608 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05431608
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple MyelomaRefractory Multiple MyelomaRelapse Multiple Myeloma
Start date
2022-06-20
Primary completion
2027-06-20
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.